Assignee
ADVANCED ACCELERATOR APPLICATIONS INT SA
CH·4 granted patents·5 pending applications·10 citations·filing 2019–2024
Top patents by PatentIndex Score
9 records- 0192US11083805B2Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancerADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2019·Granted Aug 10, 2021·7 cites·17 claims
- 0284US12064491B2Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancerADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2021·Granted Aug 20, 2024·1 cites·9 claims
- 0384US12064490B2Radiolabeled GRPR-Antagonists for Diagnostic Imaging and Treatment of GRPR-Positive CancerADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2021·Granted Aug 20, 2024·1 cites·9 claims
- 0483US12064489B2Radiolabeled GRPR-antagonists for diagnostic imaging and treatment of GRPR-positive cancerADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2021·Granted Aug 20, 2024·1 cites·11 claims
- 0583US2024366812A1Radiolabeled GRPR-Antagonists for Diagnostic Imaging and Treatment of GRPR-Positive CancerADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2024·Application pending·0 cites
- 0652US2022008566A1Pharmaceutical Composition Comprising a Radiolabeled GRPR Antagonist and a SurfactantADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2019·Application pending·0 cites
- 0752US2024050597A1Radiolabelled alpha-v beta-3 and/or alpha-v beta-5 integrins antagonist for use as theragnostic agentADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2021·Application pending·0 cites
- 0839US2023321285A1Method of treating psma-expressing cancersADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2021·Application pending·0 cites
- 0939US2023338587A1Method of treating psma-expressing cancersADVANCED ACCELERATOR APPLICATIONS INT SA·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →